SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-001508
Filing Date
2024-01-05
Accepted
2024-01-05 16:45:22
Documents
13
Period of Report
2023-12-29
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 50624
  Complete submission text file 0001493152-24-001508.txt   279270

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vhaq-20231229.xsd EX-101.SCH 3709
3 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vhaq-20231229_def.xml EX-101.DEF 27241
4 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vhaq-20231229_lab.xml EX-101.LAB 37383
5 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vhaq-20231229_pre.xml EX-101.PRE 25857
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6571
Mailing Address 3480 PEACHTREE ROAD NE 2ND FLOOR - SUITE #112 ATLANTA GA 30326
Business Address 3480 PEACHTREE ROAD NE 2ND FLOOR - SUITE #112 ATLANTA GA 30326 4045797978
Viveon Health Acquisition Corp. (Filer) CIK: 0001823857 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39827 | Film No.: 24516836
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)